top of page
header_background_b.jpg

Colorado PROSPER offers a variety of FREE psychiatry support to health care providers who are managing perinatal patients with behavioral or mental health concerns. This includes consultation programs, training and education and more.

PERINATAL MENTAL HEALTH & SUBSTANCE USE
CONSULTING + ACCESS PROGRAM

In collaboration with

FREE CONSULTATIONS & REFERRALS

Screening Tools

Recommended Guidelines

At Colorado PROSPER we are committed to providing resources designed to assist perinatal care providers in identifying and responding effectively to the mental health and substance use needs of pregnant and postpartum patients. ALL perinatal women should be screened for mental health conditions. ACOG’s Committee recommends the use of validated screeners (EPDS or PHQ9/GAD7) to screen for PMADs at: •Initial postpartum •Start of third trimester •Postpartum visits Screen for bipolar disorder before starting initial pharmacotherapy with MDQ, PDF available for download below. AAP (American Academy of Pediatrics): •1-,2-,4- and 6- month well-infant visits for the birthing parent •6 month visit for the mother’s partner •EPDS is validated for any caregiver in the perinatal period Substance Use Screening •Who? Universally, everyone •What? Validated, evidenced-based screening tools - e.g. 5P’s, NIDA Quick Screen •When? As early as possible (1st prenatal visit – ACOG; every trimester-WHO) •Why? Determine risk, screening associated w/decreased use, context for use and often high motivation to change during pregnancy/postpartum. If you are not a healthcare professional and you self-tested with any of the provided screeners, we encourage you to schedule an appointment with your primary care or obstetric provider to discuss your screening results. We are a consultation line for healthcare providers and do not provide services to patients and families directly. Reference: The American College of Obstetricians and Gynecologists. (2024). Implementing perinatal mental health screening. The American College of Obstetricians and Gynecologists (ACOG). ACOG.org

pg_background_e.png
Edinburgh Postnatal Depression Scale1 (EPDS)

Edinburgh Postnatal Depression Scale1 (EPDS)

The 10-question Edinburgh Postnatal Depression scale (EPDS) is a valuable and efficient way of identifying patients at risk for “perinatal” depression.

Screenshot 2024-10-31 at 1.43.00 PM.png

Generalized Anxiety Disorder 7-item (GAD-7)

The Generalized Anxiety Disorder 7-item (GAD-7) is a easy to perform initial screening tool for generalized anxiety disorder

Mood Disorder Questionnaire (MDQ)

Mood Disorder Questionnaire (MDQ)

The Mood Disorder Questionnaire (MDQ) was developed by a team of psychiatrists, researchers and consumer advocates to address the need for timely and accurate evaluation of bipolar disorder.

Patient Health Questionnaire

Patient Health Questionnaire (PHQ)

The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders.

5ps.jpg

5P's Substance Use Disorder Screening Tool

During pregnancy health can be affected by emotional problems, alcohol, tobacco, other drug use and violence. Health can also be affected when these same problems are present in people who are close to them. Knowing about these behaviors helps us provide you and your baby the best possible care.

NIDA.jpg

NIDA Quick Screen

The questions in the NIDA Quick Screen relate to experience with alcohol, cigarettes, and other drugs. Some of the substances talked about are prescribed by a doctor (like pain medications).

bottom of page